Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Why Index Levels Matter explains the impact of index readings on market perception and strategy, guiding you to smarter investment choices.
23,364 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
The Treasury Department will assume management of about $180 billion in defaulted federal student loans, a decisive s...
Iran carried out the executions of a 19-year-old star wrestler and two others, sparking investor worry about sanction...
Kevin O’Leary’s $4.2 billion Softkey exit in 1999 turned him into a millionaire, but the moment was surprisingly low-...
A new Ripple survey shows banks leaning into digital assets, with stablecoins leading cash-flow efficiency. For XRP, ...
Medicare is tightening oversight on hospice providers amid rising admissions and fraud concerns. The crackdown could ...
A new working paper finds cfos admit privately that AI-related layoffs will rise ninefold this year, yet the total re...
A New Mexico jury found Meta's platforms harmful to children's mental health, ordering a $375 million penalty and sig...
A headline about Palantir and a high-stakes defense AI plan could reshape risk and opportunity. This guide breaks dow...
Cardano just caught major regulatory clarity, a development that could reduce some risk for investors. This guide bre...
Anchorage Digital Bank announced a regulatory milestone, bringing Tron inside the U.S. regulatory perimeter. The move...
Dow's Jim Fitterling cautions that the Iran war is disrupting petrochemical supply, potentially fueling inflation thr...